We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

197 hedge funds and large institutions have $1.92B invested in Select Medical in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,390% more call options, than puts

Call options by funds: $3.67M | Put options by funds: $246K

2% more capital invested

Capital invested by funds: $1.87B → $1.92B (+$46.6M)

0.18% more ownership

Funds ownership: 142.93%143.12% (+0.18%)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

1% less funds holding

Funds holding: 198197 (-1)

16% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 75

Holders
197
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
63
Reduced
75
Closed
24
Calls
$3.67M
Puts
$246K
Net Calls
+$3.42M
Net Calls Change
+$3.55M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
PAR Capital Management
Massachusetts
$11.4M
Millennium Management
27
Millennium Management
New York
$11M -$4.17M -402,802 -27%
Deutsche Bank
28
Deutsche Bank
Germany
$10.9M -$3.32M -320,676 -23%
BA
29
Broadview Advisors
Wisconsin
$9.76M +$135K +12,992 +1%
SGCIA
30
Smith Graham & Co Investment Advisors
Texas
$9.47M -$981K -94,711 -9%
FP
31
Foundry Partners
Minnesota
$9.24M -$5.37M -518,885 -36%
Prudential Financial
32
Prudential Financial
New Jersey
$8.36M -$825K -79,656 -9%
Goldman Sachs
33
Goldman Sachs
New York
$7.87M -$551K -53,199 -6%
Wellington Management Group
34
Wellington Management Group
Massachusetts
$7.7M +$8.04M +776,424 New
MPAM
35
Monarch Partners Asset Management
Massachusetts
$7.45M -$3.11M -300,839 -29%
PPA
36
Parametric Portfolio Associates
Washington
$6.68M -$339K -32,721 -5%
Legal & General Group
37
Legal & General Group
United Kingdom
$5.41M +$405K +39,117 +8%
JP Morgan Chase
38
JP Morgan Chase
New York
$5.25M -$4.86M -469,529 -47%
TCIM
39
TIAA CREF Investment Management
New York
$5.13M -$751K -72,566 -12%
LG
40
Leuthold Group
Minnesota
$4.93M +$549K +53,043 +12%
TA
41
Teachers Advisors
New York
$4.75M +$685K +66,128 +16%
PAM
42
Panagora Asset Management
Massachusetts
$4.69M -$58.2K -5,625 -1%
Wells Fargo
43
Wells Fargo
California
$4.68M -$2.27M -219,397 -32%
Man Group
44
Man Group
United Kingdom
$4.65M +$1.98M +191,357 +69%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$4.62M -$129K -12,423 -3%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$4.05M
SEI Investments
47
SEI Investments
Pennsylvania
$3.84M +$3.99M +384,949 +16,040%
O
48
OppenheimerFunds
New York
$3.72M +$378K +36,485 +11%
OAM
49
Oxford Asset Management
United Kingdom
$3.71M +$2.82M +272,585 +264%
SIM
50
Spark Investment Management
New York
$3.68M +$3.85M +371,571 New

SEM Hedge Fund Activity: Q3 2018 in Review

197 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2018, worth a combined $1.92B — up 2.5% from $1.87B a quarter earlier.

Fund positioning in SEM was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 63 added to existing stakes and 75 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $33.1M. The largest seller was OrbiMed, cutting an estimated $77.6M.

  • 197 institutional investors held Select Medical (SEM) as of Q3 2018, down from 198 in Q2 2018.
  • Funds reported $1.92B of Select Medical stock for Q3 2018, up 2.5% quarter-over-quarter.
  • 24 funds opened new Select Medical positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Select Medical buyer in Q3 2018 was TimesSquare Capital Management, an estimated $33.1M added.
  • The largest Select Medical seller in Q3 2018 was OrbiMed, an estimated $77.6M sold.

Based on aggregated 13F filings for Q3 2018.